Objective Evidence shows that the conventional cardiometabolic risk factors do not fully explain the burden of microvascular complications in type 2 diabetes (T2D). One potential …
B Hodges, Z Ivy, RM Cronin, M Rodeghier… - Blood …, 2022 - ashpublications.org
COI notes: MRD and his institution are the sponsors of two externally funded research investigatorinitiated projects. Global Blood Therapeutics will provide funding for the cost of …
Background Existing reports show a bidirectional association between type 2 diabetes (T2D) and pulmonary dysfunction. Obesity, which is causally related to both T2D and pulmonary …